We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where Cyclo Therapeutics, Inc. (NASDAQ:CYTH) stands against the other micro cap ...
As of February 10, 2023, the average one-year price target for Cyclo Therapeutics is $5.10. The forecasts range from a low of $5.05 to a high of $5.25. The average price target represents an increase ...
Fintel reports that on September 27, 2023, Maxim Group upgraded their outlook for Cyclo Therapeutics Inc - (NASDAQ:CYTH) from Hold to Buy. As of March 27, 2023, the average one-year price target for ...
Cyclo Therapeutics, Inc. (CYTH) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.29 per share a year ago. These ...
Clinical-stage biotechs Applied Molecular Transport (NASDAQ:AMTI) and Cyclo Therapeutics (NASDAQ:CYTH) announced a merger agreement on Thursday whereby Applied Molecular (AMTI) will merge with Cyclo ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Cyclo Therapeutics, Inc. (NASDAQ: CYTH) and Applied Molecular Transport Inc. is fair to ...
Ctd Holdings Inc (CYTH) stock has faced a significant downturn, touching a 52-week low of $0.59, marking a stark contrast to its performance over the past year. According to InvestingPro data, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results